Mira Pharmaceuticals Inc (FRA:K6S) Stock News, Headlines & Updates
Mira Pharmaceuticals Inc Stock News from GuruFocus
- 1
Jun 24, 2024
MIRA Pharmaceuticals Announces Ketamir-2 Shows Promising Safety Profile in Comparison to Traditional Ketamine In Preclinical Testing
PRNewswire • 8:00am
Jun 10, 2024
Mira Pharmaceuticals Announces Positive Preclinical Study Results For Its Novel Oral ketamine Analog, Ketamir-2, Paving the Way for IND Submission Later This Year
PRNewswire • 8:00am
May 29, 2024
Mira Pharmaceuticals Announces DEA Rules MIRA-55, a Novel Oral Pharmaceutical Marijuana Analog, Is Not Classified as a Controlled Substance
PRNewswire • 8:00am
May 21, 2024
MIRA Pharmaceuticals in Discussions with Memorial Sloan Kettering to Collaborate on Preclinical Cancer Pain Model Utilizing The Company's Novel Oral Ketamine Analog
PRNewswire • 8:00am
May 20, 2024
Mira Pharmaceuticals Advances Preclinical Trials Towards an IND Submission This Year for Ketamir-2, a Differentiated Oral Ketamine Analog
PRNewswire • 8:00am
Apr 02, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news